# Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma

> **NCT00293527** · PHASE2 · WITHDRAWN · sponsor: **Ohio State University Comprehensive Cancer Center**

## Conditions studied

- Renal Cancer

## Interventions

- **DRUG:** Interferon Alpha-2b

## Key facts

- **NCT ID:** NCT00293527
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2006-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawn in October 2006, no longer of interest
- **Last updated:** 2013-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00293527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00293527, "Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00293527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*